ODDB.org: Open Drug Database

Accord Healthcare AG - Deferasirox Accord 90 mg, Filmtabletten

Swissmedic Registration	67517	Sequence	01
Product name	Deferasirox Accord 90 mg	Description	Filmtabletten
ATC-Classification	V03AC03	ATC-Description	Deferasirox
Introduction of Sequence	01.02.2021

Composition

deferasiroxum 90 mg, cellulosum microcristallinum, carmellosum natricum conexum, hydroxypropylcellulosum substitutum humile, poloxamerum 188, povidonum K 30, lactosum monohydricum 27.025 mg, silica colloidalis anhydrica, natrii stearylis fumaras, ricini oleum hydrogenatum, Überzug: hypromellosum, propylenglycolum, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.5447 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Deferasirox	90 mg

BAG: Active Agent	Dose
Deferasirox	90 mg

Inactive agents	Dose	additional_information
(Flavum)
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Hydroxypropylcellulosum Substitutum Humile
Hypromellosum		Überzug
Lactose Monohydrate	27.025 mg
Natrii Stearylis Fumaras
Poloxamer	188
Povidonum K	30
Pro Compresso Obducto
Propylenglycol
Ricini Oleum Hydrogenatum
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30	143.39	172.35	B	SL	No
002	90	365.68	414.10	B	SL	No

2025	©ywesee GmbH